GB201604182D0 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer - Google Patents
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerInfo
- Publication number
- GB201604182D0 GB201604182D0 GBGB1604182.4A GB201604182A GB201604182D0 GB 201604182 D0 GB201604182 D0 GB 201604182D0 GB 201604182 A GB201604182 A GB 201604182A GB 201604182 D0 GB201604182 D0 GB 201604182D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- quinolin
- imidazo
- compounds
- treating cancer
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- NSHFLKZNBPJNPA-UHFFFAOYSA-N imidazo[4,5-c]quinolin-2-one Chemical class C1=CC=C2C3=NC(=O)N=C3C=NC2=C1 NSHFLKZNBPJNPA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1604182.4A GB201604182D0 (en) | 2016-03-11 | 2016-03-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| TW106108065A TW201808948A (en) | 2016-03-11 | 2017-03-10 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| PCT/EP2017/055683 WO2017153578A1 (en) | 2016-03-11 | 2017-03-10 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1604182.4A GB201604182D0 (en) | 2016-03-11 | 2016-03-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201604182D0 true GB201604182D0 (en) | 2016-04-27 |
Family
ID=55952185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1604182.4A Ceased GB201604182D0 (en) | 2016-03-11 | 2016-03-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB201604182D0 (en) |
| TW (1) | TW201808948A (en) |
| WO (1) | WO2017153578A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021139814A1 (en) * | 2020-01-09 | 2021-07-15 | 南京明德新药研发有限公司 | Quinoline imidazole compound and application thereof |
| EP4171651A1 (en) | 2020-06-24 | 2023-05-03 | AstraZeneca UK Limited | Combination of antibody-drug conjugate and atm inhibitor |
| JP7669473B2 (en) * | 2020-09-21 | 2025-04-28 | ウェイ ジョン | Substituted 1-(3,3-difluoropiperidin-4-yl)-imidazo[4,5-c]quinolin-2-one compounds having blood-brain barrier permeability |
| EP3992191A1 (en) | 2020-11-03 | 2022-05-04 | Deutsches Krebsforschungszentrum | Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors |
| WO2022128833A1 (en) | 2020-12-15 | 2022-06-23 | Merck Patent Gmbh | Solid transition metal-ligand complexes |
| CN115232122B (en) * | 2021-04-23 | 2024-05-31 | 石药集团中奇制药技术（石家庄）有限公司 | Alkyne compound as well as preparation and application thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| AU719434B2 (en) | 1996-02-13 | 2000-05-11 | Astrazeneca Ab | Quinazoline derivatives as VEGF inhibitors |
| ES2169355T3 (en) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | DERIVATIVES OF 4-ANILINOQUINAZOLINA. |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| WO2010139747A1 (en) * | 2009-06-04 | 2010-12-09 | Novartis Ag | 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
| CN102372711B (en) | 2010-08-18 | 2014-09-17 | 山东轩竹医药科技有限公司 | Imidazo quinoline PI3K and mTOR (mammalian target of rapamycin) dual inhibitor |
| CN102399218A (en) | 2010-09-16 | 2012-04-04 | 和记黄埔医药（上海）有限公司 | Triheterocyclic compounds and their use as PI3K inhibitors |
-
2016
- 2016-03-11 GB GBGB1604182.4A patent/GB201604182D0/en not_active Ceased
-
2017
- 2017-03-10 TW TW106108065A patent/TW201808948A/en unknown
- 2017-03-10 WO PCT/EP2017/055683 patent/WO2017153578A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| TW201808948A (en) | 2018-03-16 |
| WO2017153578A1 (en) | 2017-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258818A (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL248397B (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL258828A (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| GB201608227D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| GB201516504D0 (en) | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer | |
| ZA201904695B (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| PL3640251T3 (en) | 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer | |
| IL269272A (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL263120A (en) | Adenosine derivatives for use in the treatment of cancer | |
| IL266198A (en) | Liposomal formulation for use in the treatment of cancer | |
| GB201604182D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| PT3790879T (en) | Triazolopyrimidine compounds and their use in treating cancer | |
| IL266128B (en) | Naphthyridinone derivatives and their use in the treatment of arrhythmia | |
| IL261648A (en) | Cinnolin-4-amine compounds and their use in treating cancer | |
| HK1255487A1 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| HK40022419A (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| GB201613403D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer | |
| HK40031579A (en) | Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer | |
| GB201516220D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer | |
| ZA201704727B (en) | New imidazo[1,2-a]quinoxalines and derivates thereof for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |